Our most advanced project’s lead optimization results published

Novel 8-hydroxyquinoline pharmacophore scaffold was synthetized by Avidin’s Medicinal Pharmacolgy department which has been shown to possess a range of activities as metal chelation, enzyme inhibition, cytotoxicity and cytoprotection. Based on our previous findings we set out to optimize the scaffold for cytoprotective activity for its potential application in central nervous system related diseases. A 48-membered Betti-library was constructed by the utilization of formic acid mediated industrial-compatible coupling with sets of aromatic primary amines such as anilines, oxazoles, pyridines and pyrimidines with (hetero)aromatic aldehydes and 8-hydroxiquinoline derivatives. After column chromatography and re-crystallization, the corresponding analogues were obtained in yields of 13-90%. The synthesized analogs were optimized with the utilization of a cytoprotection assay with chemically induced oxidative stress and the most active compounds were further tested in orthogonal assays; a real time cell viability method, a FACS based assay measuring mitochondrial membrane potential changes and gene expression analysis. The best candidates showed potent, nanomolar activity in all test systems and support the need for future studies in animal models of CNS disorders (doi:10.3390/molecules23081934).